Search by Drug Name or NDC
NDC 00067-6296-01 LAMISIL 0.84 g/125mL Details
LAMISIL 0.84 g/125mL
LAMISIL is a TOPICAL AEROSOL, SPRAY in the HUMAN OTC DRUG category. It is labeled and distributed by GlaxoSmithKline Consumer Healthcare Holdings (US) LLC. The primary component is TERBINAFINE HYDROCHLORIDE.
Product Information
NDC | 00067-6296 |
---|---|
Product ID | 0067-6296_54dd4021-d70c-426b-9506-1d1f1819782f |
Associated GPIs | |
GCN Sequence Number | n/a |
GCN Sequence Number Description | n/a |
HIC3 | n/a |
HIC3 Description | n/a |
GCN | n/a |
HICL Sequence Number | n/a |
HICL Sequence Number Description | n/a |
Brand/Generic | n/a |
Proprietary Name | LAMISIL |
Proprietary Name Suffix | AT |
Non-Proprietary Name | TERBINAFINE HYDROCHLORIDE |
Product Type | HUMAN OTC DRUG |
Dosage Form | AEROSOL, SPRAY |
Route | TOPICAL |
Active Ingredient Strength | 0.84 |
Active Ingredient Units | g/125mL |
Substance Name | TERBINAFINE HYDROCHLORIDE |
Labeler Name | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC |
Pharmaceutical Class | Allylamine Antifungal [EPC], Allylamine [CS] |
DEA Schedule | n/a |
Marketing Category | NDA |
Application Number | NDA021124 |
Listing Certified Through | 2024-12-31 |
Package
Package Images

NDC 00067-6296-01 (00067629601)
NDC Package Code | 0067-6296-01 |
---|---|
Billing NDC | 00067629601 |
Package | 125 mL in 1 CAN (0067-6296-01) |
Marketing Start Date | 2018-03-07 |
NDC Exclude Flag | N |
Pricing Information | N/A |
Standard Product Labeling (SPL)/Prescribing Information SPL 03659e44-7406-4064-8141-f552315dd05f Details
Uses
Warnings
Directions
- •
- adults and children 12 years and over:
- •
- wash the affected area with soap and water and dry completely before applying
- •
- to open remove clear cap
- •
- hold can 4" to 6" from skin. Press and hold to spray a thin layer over affected area
- •
- spray affected area once a day (morning or night) for 1 week or as directed by a doctor
- •
- release to stop spray
- •
- wipe excess from spray opening after each use
- •
- return cap to can
- •
- for athlete’s foot between the toes spray twice a day (morning and night) for 1 week or as directed by a doctor. Wear well-fitting, ventilated shoes. Change shoes and socks at least once daily.
- •
- for jock itch and ringworm spray affected area once a day (morning or night) for 1 week or as directed by a doctor
- •
- wash hands after each use
- •
- children under 12 years: ask a doctor
Principal Display Panel
NDC 0067-6296-01
TERBINAFINE HYDROCHLORIDE SOLUTION 1% - ANTIFUNGAL
LAMISILAT®SPRAY
Clinically proven to cure most athlete’s foot between the toes
Full prescription strength
Relieves itching, burning, cracking and scaling
Net Contents 125 ml (4.2 fl oz)
The only 1 week (twice a day)athlete’s foot spray
Trademarks are owned by or licensed to the GSK group of companies.
1-800-330-9876
Distributed by:
GSK Consumer Healthcare,
Warren, NJ 07059
©2017 GSK or its licensor.
13059
INGREDIENTS AND APPEARANCE
LAMISIL
AT
terbinafine hydrochloride aerosol, spray |
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
|||||||||||||||
|
Labeler - GlaxoSmithKline Consumer Healthcare Holdings (US) LLC (079944263) |
Revised: 8/2021
Document Id: 54dd4021-d70c-426b-9506-1d1f1819782f
Set id: 03659e44-7406-4064-8141-f552315dd05f
Version: 4
Effective Time: 20210816